Stay updated with breaking news from Viscient bio inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Interview with the Founder and Executive Chairman: Organovo Holdings Inc. (NASDAQ:ONVO) twst.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from twst.com Daily Mail and Mail on Sunday newspapers.
Trailblazing work with 3D Human Liver Models Yields Accurate MASH (formerly NASH) Phenotype streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Viscient Bio, Inc. ("Viscient") today announced it has identified the world s first drug candidate discovered primarily using 3D bioprinted. ....
Organovo uses different 3D tissue technologies to see the best biology of the intestine, which gets us to the best novel therapeutics, new drugs for intestinal diseases, especially for Crohn’s disease and ulcerative colitis. ....